NRG-GY026, "A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma," (#NCT05256225)
Details
Age
Adult
Type of Study
Treatment
Locations
Cherry Creek Medical Center
Highlands Ranch Hospital
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Marisa Moroney, MD
Study ID
Protocol Number: 22-1764
More information available at ClinicalTrials.gov: NCT05256225
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers